BEST VITELLIFORM MACULAR DYSTROPHY IN AFGHAN TWINS
AbstractBest vitelliform macular dystrophy is the second most common type of hereditary fundus dystrophies. Our case report describes twin brothers of Afghan family who developed Best vitelliform macular dystrophy. One of them developed choroidal neovascularization in one eye which was treated with single intravitreal injection of bevacizumab. The patient showed stable vision and did not have any recurrence until 3 years of follow up. Many cases of familial Best vitelliform macular dystrophy have been described in medical literature but our report is unique as it presents twin brothers with Best vitelliform macular dystrophy which has never been described before.Keywords: Best vitelliform macular dystrophy, Choroidal neovascularization, Optical coherence tomography
Kanski JJ. Hereditary fundus dystrophies. In: Bowling B, editor. Kanski’s clinical ophthalmology: a systematic approach. 8th ed. s.l.: Elsevier; 2016. p.660.
Budiene B, Liutkeviciene R, Zaliuniene D. Best vitelliform macular dystrophy: literature review. Open Med 2014;9(6):784–95.
Huang S, Wu L, Wen F, Luo G, Jiang F. Follow-up of a case of vitelliform macular dystrophy over an 8-year period. Eye Sci 2014;29(3):165–9.
Griffith JF, Hess DJ, Berrocal AM. Best's vitelliform macular dystrophy in 10- and 31-month-old siblings. J Pediatr Ophthalmol Strabismus 2014;4:51.
Renner AB, Tillack H, Kraus H, Krämer F, Mohr N, Weber BH, et al. Late Onset is Common in Best Macular Dystrophy Associated with VMD2 Gene Mutations. Ophthalmology 2005;112(4):586–92.
Alisa-Victoria K, Jin-Poi T, Shatriah I, Zunaina E, Ngah NF. Choroidal neovascularization secondary to Best’s vitelliform macular dystrophy in two siblings of a Malay family. Clin Ophthalmol 2014;8:537–42.
Ruiz-Moreno O, Calvo P, Ferrández B, Torrón C. Long-term outcomes of intravitreal ranibizumab for choroidal neovascularization secondary to Best’s disease: 3-year follow-up. Acta Ophthalmol 2012;90(7):574–5.
Journal of Ayub Medical College, Abbottabad is an OPEN ACCESS JOURNAL which means that all content is FREELY available without charge to all users whether registered with the journal or not. The work published by J Ayub Med Coll Abbottabad is licensed and distributed under the creative commons License CC BY ND Attribution-NoDerivs. Material printed in this journal is OPEN to access, and are FREE for use in academic and research work with proper citation. J Ayub Med Coll Abbottabad accepts only original material for publication with the understanding that except for abstracts, no part of the data has been published or will be submitted for publication elsewhere before appearing in J Ayub Med Coll Abbottabad. The Editorial Board of J Ayub Med Coll Abbottabad makes every effort to ensure the accuracy and authenticity of material printed in J Ayub Med Coll Abbottabad. However, conclusions and statements expressed are views of the authors and do not reflect the opinion/policy of J Ayub Med Coll Abbottabad or the Editorial Board.
USERS are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.
AUTHORS retain the rights of free downloading/unlimited e-print of full text and sharing/disseminating the article without any restriction, by any means including twitter, scholarly collaboration networks such as ResearchGate, Academia.eu, and social media sites such as Twitter, LinkedIn, Google Scholar and any other professional or academic networking site.